Search

Search Constraints

You searched for: Author/Creator Belic, Jelena

Search Results

1. A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study. Issue 6 (16th October 2020)

2. A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study. Issue 6 (16th October 2020)

6. Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide. Issue 5 (10th April 2018)

7. Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models. Issue 8 (13th June 2022)

8. Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach. (6th January 2020)